SCHEMBL2536455

SCHEMBL2536455

CC1(C)Cc2c(cc(Cl)cc2C(=O)O)NC1c1cccc(N2CCOCC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.44
KMO O15229 1/20 0.42
KIF11 P52732 4/20 0.41
KDM1A O60341 1/20 0.40
AKR1C3 P42330 1/20 0.40
ACLY P53396 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
BRD4 O60885 1/20 0.38
CREBBP Q92793 1/20 0.38
CYP3A4 P08684 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
SLC6A9 P48067 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
PRKDC P78527 1/20 0.36
ALDH1A1 P00352 3/20 0.36
PLK1 P53350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533037 0.90 CYP2C19 (0.40) CYP2C19KIF11KDM1AAKR1C3ACLY
SCHEMBL2527845 0.90 CYP2C19 (0.43) CYP2C19KMOKIF11MEN1KMT2A
SCHEMBL2532964 0.87 KDM1A (0.40) CYP2C19KIF11KDM1AAKR1C3ACLY
SCHEMBL2534968 0.86 CYP2C19 (0.43) CYP2C19KMOKIF11KDM1AAKR1C3
SCHEMBL2531383 0.84 CYP2C19 (0.43) CYP2C19KMOKIF11KDM1AAKR1C3
SCHEMBL2532883 0.84 CYP2C19 (0.43) CYP2C19KMOKIF11KDM1AAKR1C3
SCHEMBL2530149 0.83 CYP2C19 (0.43) CYP2C19KMOKIF11AKR1C3ACLY
SCHEMBL2530945 0.83 CYP2C19 (0.43) CYP2C19KMOKIF11AKR1C3MEN1
SCHEMBL14331242 0.82 CYP2C19 (0.41) CYP2C19KMOKIF11GAABRD4
SCHEMBL15509690 0.80 CYP2C19 (0.42) CYP2C19KMOKIF11AKR1C3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885KMO 2473/4885KIF11 3355/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885KMO 2473/4885KIF11 3355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.